Picture of Terveystalo Oyj logo

TTALO — Terveystalo Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Finland's Terveystalo Q1 revenue falls 11% on weak demand; keeps 2026 view

Overview

Finland healthcare provider's Q1 revenue fell 11% yr/yr amid weak demand

Adjusted EBIT dropped as volumes and margins declined

Company cites exceptionally weak demand, low consumer confidence, and cost-cutting by clients

Outlook

Guidance for 2026 remains unchanged.

Terveystalo expects 2026 adjusted EBIT of EUR 135-165 mln

Company expects demand environment to gradually recover in 2026, with a challenging first half

Revenue from Portfolio Businesses outsourcing projected to decrease by about EUR 20 mln due to expiring contracts

Result Drivers

WEAK DEMAND - Co said demand for health services was exceptionally weak across all customer groups, citing low consumer confidence, mild flu season, client cost-cutting, and cautious public sector purchasing

PORTFOLIO BUSINESSES - Revenue in Portfolio Businesses fell due to expiring outsourcing contracts and lower public sector purchases; demand for staffing services remained weak

COST ADJUSTMENTS - Co said it adjusted its cost structure and operations to match weak demand, supporting profitability despite lower volumes

Company press release: ID:nWkr34qJDw

Key Details

MetricBeat/MissActualConsensus Estimate
Q1 RevenueEUR 308.20 mln
Q1 EPSEUR 0.14
Q1 Adjusted EBITAEUR 39.30 mln
Q1 EBITEUR 26.60 mln
Q1 EBITAEUR 33.40 mln
Analyst Coverage The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and 1 "sell" or "strong sell" The average consensus recommendation for the healthcare facilities & services peer group is "buy" Wall Street's median 12-month price target for Terveystalo Oyj is €11.20, about 37.3% above its April 23 closing price of €8.16 The stock recently traded at 10 times the next 12-month earnings vs. a P/E of 11 three months ago For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com. (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Terveystalo Oyj

See all news